The development of bone marrow transplantation as a treatment for patients with lymphoma - Twentieth Richard and Hinda Rosenthal Foundation Award Lecture

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 829-836

  Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PREDNISONE; VINDESINE;

AGED; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONFERENCE PAPER; HISTORY OF MEDICINE; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

AWARDS AND PRIZES; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III; CLINICAL TRIALS, PHASE III AS TOPIC; HISTORY, 20TH CENTURY; HUMANS; LYMPHOMA; MEDICAL ONCOLOGY; UNITED STATES;

EID: 0030952845     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (84)

1. Osgood, E. E., Riddle, M. C., and Mathews, T. J. Aplastic anemia treated with daily transfusions and intravenous marrow: case report. Ann. Intern. Med., 13: 357-367, 1939.
2. Thomas, E. D., and Storb, R. Techniques for human marrow grafting. Blood, 36: 507, 1970.
3. Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, L., Neiman, P. E., Lerner, K. G., Glucksberg, H., and Buckner, C. D. Bone-marrow transplantation. N. Engl. J. Med., 292: 832-843, 895-902, 1975.
4. Kurnick, N. B., Montano, A., Gerdes, J. C., and Feder, B. H. Preliminary observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. Ann. Int. Med., 49: 973, 1958.
5. Appelbaum, F. R., Herzig, G. P., Ziegler, J. L., Graw, R. G., Levine, A. S., and Deisseroth, A. B. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood, 52: 85-95, 1978.
6. Korbling, M., Dorken, B., Ho, A. D., Pezzuto, A., Hunstein, W., and Fliedner, T. M. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood, 67: 529-532, 1986.
7. Kessinger, A., Armitage, J. O., Landmark, J. D., and Weisenburger, D. D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cell. Exp. Hematol., 14: 192-196, 1986.
8. Gianni, A. M., Siena, S., Bregni, M., Tarella, C., Stern, A. C., Pileri, A., and Bonadonna, G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, 2: 580-585, 1989.
9. DeVita, V. T., Jr., Simon, R. M., Hubbard, S. M., Young, R. C., Berard, C. W., Moxley, J. H., III, Frei, E., III, Carbone, P. P., and Canellos, G. P. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann. Int. Med., 92: 587-595, 1980.
10. Levitt, M., Marsh, J. C., DeConti, R., Mitchell, M. S., Keel, R. T., Farber, L. R., and Bertino, J. R. Combination sequential chemotherapy in advanced reticulum cell sarcoma. Cancer (Phila.), 29: 630-636, 1972.
11. DeVita, V. T., Jr., Canellos, G. P., Chabner, B., Schein, P., Hubbard, S. P., and Young, R. C. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet, 1: 248-250, 1975.
12. Jagannath, S., Dicke, K. A., Armitage, J. O., Cabanillas, F. F., Horwitz, L. J., Vellekoop, L., Zander, A. R., and Spitzer, G. High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Ann. Intern. Med., 104: 163-168, 1986.
13. Carella, A. M., Congiu, A. M., Gaozza, E., Mazza, P., Ricci, P., Visani, G., Meloni, G., Cimino, G., Mangoni, L., Coser, P., Luigi Cetto, G., Cimino, R., Allessandrino, E. P., Brusamolino, E., Santini, G., Tura, S., Mandelli, F., Rizzoli, V., Bernasconi, C., and Marmont, A. M. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. J. Clin. Oncol., 6: 1411-1416, 1988.
14. Gribben, J. G., Linch, D. C., Singer, C. R. J., McMillan, A. K., Jarrett, M., and Goldstone, A. H. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. Blood, 73: 340-344, 1989.
15. Armitage, J. O., Bierman, P. J., Vose, J. M., Anderson, J. R., Weisenburger, D. D., Kessinger, A., Reed, E. C., Vaughan, W. P., Coccia, P. F., and Purtilo, D. T. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am. J. Med., 91: 605-611, 1991.
16. Horning, S. J., Negrin, R. S., Chao, N. J., Long, G. D., Hoppe, R. T., and Blume, K. G. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J. Clin. Oncol., 12: 2552-2558, 1994.
17. Phillips, G. L., Wolff, S. N., Herzig, R. H., Lazarus, H. M., Fay, J. W., Lin, H-S., Shina, D. C., Glasgow, G. P., Griffith, R. C., Lamb, C. W., and Herzig, G. P. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood, 73: 2086-2092, 1989.
18. Reece, D. E., Barnett, M. J., Connors, J. M., Fairey, R. N., Greer, J. P., Herzig, G. P., Herzig, R. H., Klingemann, H-G., O'Reilly, S. E., Shepherd, J. D., Spinelli, J. J., Voss, N. J., Wolff, S. N., and Phillips, G. L. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J. Clin. Oncol., 9; 1871-1879, 1991.
19. Crump, M., Smith, A. M., Brandwein, J., Couture, F., Sherret, H., Sutton, D. M. C., Scott, J. G., McCrae, J., Murray, C., Pantalony, D., Sutcliffe, S. B., and Keating, A. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. Importance of disease status at transplant. J. Clin. Oncol., 1: 704-711, 1993.
20. Gianni, A. M., Siena, S., Bregni, M., Lombardi, F., Gandola, L., Di Nicola, M., Magni, M., Peccatori, F., Valagussa, P., and Bonadonna, G. High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease - a 6-year update. Ann. Oncol., 4: 889-891, 1993.
21. Yahalom, J., Gulati, S. C., Toia, M., Maslak, P., McCarron, E. G., O'Brien, J. P., Portlock, C. S., Straus, D. J., Phillips, J., and Fuks, Z. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J. Clin. Oncol., 6: 1062-1070, 1993.
22. Reece, D. E., Connors, J. M., Spinelli, J. J., Barnett, M. J., Fairey, R. N., Klingemann, H. G., Natel, S. H., O'Reilly, S., Shepherd, J. D., Sutherland, H. J., Voss, N., Chan, K-W., and Phillips, G. L. Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83: 1193-1199, 1994.
23. Chopra, R., McMillan, A. K., Linch, D. C., Yuklea, S., Taghipour, G., Pearce, R., Patterson, K. G., and Goldstone, A. H. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood, 81: 1137-1145, 1993.
24. Bierman, P. J., Bagin, R. G., Jagannath, S., Vose, J. M., Spitzer, G., Kessinger, A., Dicke, K. A., and Armitage, J. O. High-dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease. Long term follow-up in 128 patients. Ann. Oncol., 4: 767-773, 1993.
25. Nademanee, A., O'Donnell, M. R., Snyder, D. S., Schmidt, G. M., Parker, P. M., Stein, A. S., Smith, E. P., Molina, A., Stepan, D. E., Somolo, G., Margolin, K. A., Sniecinski, I., Dagis, A. C., Niland, J., Pezner, R., and Forman, S. J. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease. Results in 85 patients with analysis of prognostic factors. Blood, 85: 1381-1390, 1995.
26. Bums, L. J., Daniels, K. A., McGlave, P. B., Miller, W. J., Ramsay, N. K. C., Kersey, J. H., and Weisdorf, D. J. Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival. Bone Marrow Transplant., 16: 13-18. 1995.
27. Jagannath, S., Armitage, J. O., Dicke, D. A., Tucker, S. L., Velasquez, W., Smith, K., Vaughan, W. P., Kessinger, A., Horwitz, L. J., Hagemeister, F. B., McLaughlin, P., Cabanilla, F., and Spitzer, G. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J. Clin. Oncol., 7: 179-185, 1989.
28. Bierman, P. J., Anderson, J. R., Freeman, M. B., Vose, J. M., Kessinger, A., Bishop, M. R., and Armitage, J. O. High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann. Oncol., 7: 151-156, 1996.
29. Spinolo, J. A., Jagannath, S., Velasquez, W., Spitzer, G., Cabanillas, F., Hagemeister, F., Horwitz, L. J., and Dicke, K. A. Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease. Leuk. Lymphoma, 9: 71-77, 1993.
30. Moormeier, J. A., Williams, S. F., Kaminer, L. S., Ellis, E. D., Garner, M., Farah, R., Weichselbaum, R. R., and Bitran, J. D. Autologous hone marrow transplantation followed by involved field radiotherapy in patients with relapsed or refractory Hodgkin's disease. Leuk. Lymphoma, 5: 243-248, 1991.
31. Reece, D. E., Barnett, M. J., Shepherd, J. D., Hogge, D. E., Klasa, R. J., Natel, S. H., Sutherland, H. J., Klingemann, H. G., Fairey, R. N., Voss, N. J., Connors, J. M., O'Reilly, S. E., Spinelli, J. J., and Phillips, G. L. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VPI6-213) with or without cisplatin (CBV ± P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Blood, 86: 451-456, 1995.
32. Philip, T., Armitage, J. O., Spitzer, G., Chauvin F., Jagannath, S., Cahn, J. Y., Colombat, P., Goldstone, A. H., Gorin, N. C., Flesh, M., Laporte, J. P., Maraninchi, D., Pico, J. L., Bosly, A., Anderson, C., Schots, R., Biron, P., Cabanillas, R., and Dicke, K. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N. Engl. J. Med., 316: 1493-1498, 1987.
33. Colombat, P., Gorin, N-C., Lemonnier, M-P., Binet, C., Laporte, J-P., Douay, L., Desbois, I., Lopez, M., Lamagnere, J-P., and Najman, A. The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. J. Clin. Oncol., 8: 630-637, 1990.
34. Phillips, G. L., Fay, J. W., Herzig, R. H., Lazarus, H. M., Wolff, S. N., Lins, H-S., Shina, D. C., Glasgow, G. P., Griffith, R. C., Lamb, C. W., and Herzig, G. P. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation. Blood, 75: 831-838, 1990.
35. Petersen, F. B., Appelbaum, F. R., Hill, R., Fisher, L. D., Bigelow, C. L., Sanders, J. E., Sullivan, K. M., Bensinger, W. I., Witherspoon, R. P., Storb, R., Clift, R. A., Fefer, A., Press, O. W., Weiden, P. L., Singer, J., Thomas, E. D., and Buckner, C. D. Autologous marrow transplantation for malignant lymphoma. A report of 101 cases from Seattle. J. Clin. Oncol., 8: 638-647, 1990.
36. Weisdorf, D. J., Haake, R., Miller, W. J., McGlave, P. B., LeBien, T. W., Vallera, D. A., Lasky, L. C., Kim, T. H., Peterson, B. A. Ramsay, N. K. C., Kersey, J. H., and Hurd, D. D. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging. Bone Marrow Transplant., 8: 135-142, 1991.
37. Lazarus, H. M., Crilley, P., Ciobanu, N., Creger, R. J., Fox, R. M., Shina, D. C., Bulova, S. I., Gucalp, R., Cooper, B. W., Topolsky, D., Soegiarso, W., and Brodsky, I. High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J. Clin. Oncol., 10: 1682-1689, 1992.
38. Gulati, S., Yahalom, J., Acaba, L., Reich L., Motzer, R., Crown, J., Toia, M., Igarashi, T., Lemoli, R., Hanninen, E., and Doherty, M. Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. J. Clin. Oncol., 10: 936-941, 1992.
39. Vose, J. M., Anderson, J. R., Kessinger, A., Bierman, P. J., Coccia, P., Reed, E. C., Gordon, B., and Armitage, J. O. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J. Clin. Oncol., 11: 1846-1851, 1993.
40. Rapoport, A. P., Rowe, J. M., Kouides, P. A., Duerst, R. A., Abboud, C. N., Liesveld, J. L., Packman, C. H., Eberly, S., Sherman, M., Tanner, M. A., Constine, L. S., and DiPersio, J. F. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma. Value of pretransplant disease status for predicting outcome. J. Clin. Oncol., 11: 2351-2361, 1993.
41. Wheeler, C., Strawderman, M., Ayash, L., Hallowell Churchill, W., Bierer, B. E., Elias, A., Gililand, D. G., Antman, K., Guinan, E. C., Eder, J. P., Weinstein, H., Schwartz, G., Ferrara, J., Mazanet, R. Rimm, I. J., Tepler, I., McCarthy, P., Mauch, P., Ault, K., Gaynes, L., McCauley, M., Schnipper, L. E., and Antin, J. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide. J. Clin. Oncol., 11: 1085-1091, 1993.
42. Weaver, C. H., Petersen, F. B., Appelbaum, F. R., Bensinger, W. I., Press, O., Martin, P., Sandmaier, B., Deeg, H. J., Hansen, J. A., Brunvand, M., Rowley, S., Benyunes, K., Chauncey, T., Fefer, A., Hackman, R., Gooley, T., Schiffman, K., Storb, R., Sullivan, K. M., Weiden, P., Witherpoon, R., and Buckner, C. D. High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. J. Clin. Oncol., 12: 2559-2566, 1994.
43. van Besien, K., Tabocoff, J., Rodriquez, M., Andersson, B., Mehra, R., Przepiorka, D., Dimopoulos, M., Giralt, S., Suki, S., Khouri, I., Spitzer, G., Jagannath, S., Dicke, K., Le Maistre, C. F., Deisseroth, A., Cabanillas, F., and Champlin, R. E. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remission, but a high rate of regimen-related toxicity. Bone Marrow Transplant., 15: 549-555, 1995.
44. Mills, W., Chopra, R., McMillan, A., Pearce, R., Linch, D. C., and Goldstone, A. H. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J. Clin. Oncol., 13: 588-595, 1995.
45. Bosly, A., Coiffier, B., Gisselbrecht, C., Tilly, H., Auzanneau, G. Andrien, F., Herbrecht, R., Legros, M., Devaux, Y., Jaubert, J., Pignon, B., Michaux, J-L., Humblet, Y., Dupriez, B., Thyss, A, and Lederlin, P. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J. Clin. Oncol., 10: 1615-1623, 1992.
46. Colombat, P., Donadio, D., Fouillard, L., Milpied N., Tilly H., Pico, J., Abgrall, J. F., Coiffier, B., Herbrecht, R., and Phillip, T. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant., 13: 157-162, 1994.
47. Schouten, H. C., Colombat, P., Verdonck, L. F., Gorin, N. C., Bjorkstrand, B., Taghipour, G., and Goldstone, A. H. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma. The European Bone Marrow Transplant Group Experience. Ann. Oncol., 5 (Suppl. 2): S147-S149, 1994.
48. Freedman, A. S., Ritz, J., and Neuberg, D. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood, 77: 2524-2529, 1991.
49. Bastion, Y., Price, P., Haioun, C., Sonet, A., Salles, G., Marolleau, J. P., Espinouse, D., Reyes, F., Gisselbrecht, C., and Coiffier, B. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86: 3257-3262, 1995.
50. Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M., and Hunstein, W. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J. Clin. Oncol., 12: 1685-1692, 1994.
51. Vose, J., Rowlings, P. A., Lazarus, H. M., Phillips, G. L., Annitage, J. O., and Horowitz, M. M. High-dose therapy with autologous hematopoietic rescue for follicular non-Hodgkin's lymphoma. Proc. Am. Soc. Clin. Oncol., 15: 1272, 1996.
52. Schouten, H. C., Bierman, P. J., Vaughan, W. P., Kessinger, A., Vose, J. M., Weisenburger, D. D., and Armitage, J. O. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood, 74: 2579-2584, 1989.
53. Vose, J. M., Kennedy, B. C., Bierman, P. J., Kessinger, A., and Armitage. J. O. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer (Phila.), 69: 784-789, 1992.
54. Darrington, D. L., Vose, J. M., Anderson, J. R., Bierman, P. J., Bishop, M. R., Chan, W. C., Morris, M. E., Reed, E. C., Sanger, W. G., Tarantolo, S. R., Weisenburger, D. D., Kessinger, A., and Armitage, J. O. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J. Clin. Oncol., 12: 2527-2534, 1994.
55. Stone, R. M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M., Rabinowe, S. N., Aster, J. C., Leavitt, P., Mauch, P., Freedman, A. S., and Nadler, L. M. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J. Clin. Oncol., 12: 2535-2542, 1994.
56. Marolleau, J. P., Brice, P., and Gisselbrecht, C. Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphoma. J. Clin. Oncol., 11: 590-591, 1993.
57. Rohatiner, A. Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. J. Clin. Oncol., 12: 2521-2523, 1994.
58. Miller, J. S., Arthur, D. C., Litz, C. E., Neglia, J. P., Miller, W. J., and Weisdorf, D. J. Myelodysplastic syndrome after autologous bone marrow transplantation an additional late complication of curative cancer therapy. Blood, 83: 3780-3786, 1994.
59. Jones, R. J., Ambinder, R. F., Piantadosi, S., and Santos, G. W. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77: 649-653, 1991.
60. Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L. G., Momin, F., Cummings, G., and Sensenbrenner, L. L. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood, 84: 1050-1055, 1994.
61. Chopra, R., Goldstone, A. H., Pearce, R., Philip, T., Petersen, F., Appelbaum, F., DeVol, E., and Ernst, P. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. A case-controlled analysis of the European bone marrow transplant group registry data. J. Clin. Oncol., 10: 1690-1695, 1992.
62. Van Besien, K. W., Mehra, R. C., Giralt, S. A., Kantarjian, H. M., Pugh, W. C., Khouri, I. F., Moon, Y., Williams, P., Andersson, B. S., Przepiorka, D., McCarthy, P. L., Gajewski, J. L., Deissertoth, A. B., Cabanillas, F. F., and Champlin, R. Allogeneic bone marrow transplantation for poor-prognosis lymphoma. Response, toxicity, and survival depend on disease histology. Am. J. Med., 100: 299-307, 1996.
63. Anderson, J. E., Litzow, M. R., Appelbaum, F. R., Schoch, G., Fisher, L. D., Buckner, C. D., Petersen, F. B., Crawford, S. W., Press, O. W., Sanders, J. E., Bensinger, W. I., Martin, P. J., Storb, R., Sullivan, K. M., Hansen, J. A., and Thomas, E. D. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease. The 21-year Seattle experience. J. Clin. Oncol., 11: 2342-2350, 1993.
64. Gajewski, J. L., Phillips, G. L., Sobocinski, K. A., Armitage, J. O., Gale, R. P., Champlin, R. E., Herzig, R. H., Hurd, D. D., Jagannath, S., Klein, J. P., Lazarus, H. M., McCarthy, P. L., Pavlovsky, S., Petersen, F. B., Rowlings, P. A., Russell, J. A., Silver, S. M., Vose, J. M., Wiernik, P. H., Bortin, M. M., and Horowitz, M. M. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J. Clin. Oncol., 14: 572-578, 1996.
65. Milpied, N., Fielding, A. K., Pearce, R. M., Ernst, P., and Goldstone, A. H., for the European Group for Blood and Marrow Transplantation. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. J. Clin. Oncol., 14: 1291-1296, 1996.
66. Gulati, S. C., Shank, B., Black, P., Yopp, J., Koziner, B., Straus, D., Filippa, D., Kempin, S., Castro-Malaspina, H., Cunningham, I., Berman, E., Coleman, M., Langleben, A., Colvin, O. M., Fuks, Z., O'Reilly, R., and Blarkson, B. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J. Clin. Oncol., 6: 1303-1313, 1988.
67. Baro, J., Richard, C., Calavia, J., Gonzalez-San Miguel, J. D., Bello-Fernandez, C., Alsar, M. J., Gomez-Casares, M. T., Iriondo, A., Conde, E., Hermosa, V., Garijo, J., and Zubizarreta, A. Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features. Bone Marrow Transplant., 8: 283-289, 1991.
68. Nademanee, A., Schmidt, G. M., O'Donnell, M. R., Snyder, D. S., Parker, P. A., Stein, A., Smith, E., Lipsett, J. A. Sniecinski, I., Margolin, K., Somlo, G., Niland, J. C., Blume, K. G., and Forman, S. J. High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma. A pilot study. Blood. 80: 1130-1134, 1992.
69. Freedman, A. S., Takvorian, T., Neuberg, D., Mauch, P., Rabinowe, S. N., Anderson, K. C., Soiffer, R. J., Spector, N., Grossbard, M., Robertson, M. J., Blake, K., Coral, F., Canellos, G. P., Ritz, J., and Nadler, L. M. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission. A pilot study. J. Clin. Oncol., 11: 931-936, 1993.
70. Jackson, G. H., Lennard, A. L., Taylor, P. R., Carey, P., Angus, B., Lucraft, H., Evans, R. G., and Proctor, S. J. Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Br. J. Cancer. 70: 501-505, 1994.
71. Sweetenham, J. W., Proctor, S. J., Blaise, D., Laurenzi, A., Pearce, R., Taghipour, G., and Goldstone, A. H. High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-srade non-Hodgkin's lymphoma. The EBMT experience. Ann. Oncol., 5 (Suppl. 2): S155-S159, 1994.
72. Pettengell, R., Radford, J. A., Morgenstern, G. R., Scarffe, J. H., Harris, M., Voll, P. J., Deakin, D. P., Ryder, D., Wilkinson, P. M., and Crowther, D. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J. Clin. Oncol., 14: 586-592, 1996.
73. Philip, T., Hartmann, O., Biron, P., Cahn, J. Y., Pein, F., Bordigoni, P., Souillet, G., Gartner, M., Lasset, C., and Chauvin, F. High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J. Clin. Oncol., 6: 1118-1124, 1988.
74. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Dei Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J-Y., Harousseau, J-L., Coiffier, B., Biron, P., Mandelli, F., and Chauvin, F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med., 333: 1540-1545, 1995.
75. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosley, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaularad, P., and Reyes, F., for the Groupe d-Etude des Lymkphomes de l'Adulte. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. J. Clin. Oncol., 15: 1131-1137, 1997.
76. Martelli, M., Vignetti, M., Zinzani, P. L., Gherlinzoni, F., Meloni, G., Fiacchini, M., De Sanctis, V., Papa, G., Martelli, M. F., Calabresi, F., Tura, S., and Mande, F. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized Italian multicenter study. J. Clin. Oncol., 14: 534-542, 1996.
77. Verdonck, L. F., van Putten, W. L. J., Hagenbeek, A., Schouten, H. C., Sonneveld, P., Van Imhoff, G. W., Kluin-Nelemans, H., Raemaekers, J. M. M., Van Oers, R. H. J., Haak, H. L., Schots, R., Dekker, A. W., DeGast, G. C., and Lowenberg, B. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N. Engl. J. Med., 332: 1045-1051, 1995.
78. Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., DeNicola, M., Lombardi, F., Grandola, L., Tarella, C., Pileri, A., Stern, A., Valagussa, P., and Bonadonna, G. 5-year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas. Proc. Am. Soc. Clin. Oncol., 13: 1263, 1994.
79. Linen, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D., and Hudson, G. V. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet. 341: 1051-1054, 1993.
80. Carella, A. M., Carlier, P., Congiu, A., Occhini, D., Nati, S., Santini, G., Pierluigi, D., Giordana, D., Bacigalupo, A., and Damasio, E. Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. Bone Marrow Transplant., 8: 99-103, 1991.
81. Rohatiner, A. Z. S., Johnson, P. W. M., Price, C. G. A., Arnott, S. J., Amess, J. A. L., Norton, A. J., Dorey, E., Adams, K., Whelan, J. S., Matthews, J., MacCallum, P. K., Oza, A. M., and Lister, T. A. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J. Clin. Oncol., 12: 1177-1184, 1994.
82. Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., Matthews, D. C., Fisher, L. D., and Bernstein, I. D. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med., 329: 1219-1224, 1993.
83. Bierman, P. J., Vose, J. M., Leichner, P. K., Quadri, S. M., Armitage, J. O., Abrams, R. A., Klein, J., Dicke, K. A., and Vriesendrop, H. M. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J. Clin. Oncol., 11: 698-703, 1993.
84. Soiffer, R. J., Murray, C., Cochran, K., Cameron, C., Wang, E., Schow, P. W., Daley, J. F., and Ritz, J. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell depleted allogeneic bone marrow transplantation. Blood, 79: 517-526, 1992.